BACE1 and Alzheimer disease: The goal of this study was to assess CSF NRG1 levels and BACE1 concentrations in AD, MCI-AD, non-AD MCI, other dementias, and neurological controls and to compare these results with usual CSF AD CSF and synaptic biomarkers and cognition in the same groups.